Electricity industry association Eurelectric has released figures showing that 50% of public electricity generation in the E.U. came from renewables for the first time in history earlier this year. The association said Europe was decarbonizing at an unprecedented pace, with just over 50% coming from renewable energy and nearly 75% coming from non-fossil-fuel sources, up from 68% last year.
Less than a quarter of a century after the Iberian lynx was feared to be only a whisker away from extinction, populations of the animal have recovered enough across Spain and Portugal for it to be moved from “endangered” to “vulnerable” on the global red list of threatened species. According to the latest census, the lynx population on the peninsula has risen from just 94 in 2002 to 2,021 last year.
The Atlantic sturgeon – a keystone species – was driven to functional extinction in Europe in the middle of the twentieth century. Supported by a grant from Rewilding Europe’s European Wildlife Comeback fund, a pioneering initiative has seen this iconic fish reintroduced in a Swedish river for the first time. A total of 100 juvenile sturgeon were translocated from a breeding facility in the village of Born auf dem Darß, on Germany’s Baltic Sea coast, which is operated by the Mecklenburg-Vorpommern Research Center for Agriculture and Fisheries in Rostock.
For the first time, a major trigger in inflammatory bowel disease (IBD) and related conditions has been identified, and existing drugs can stamp it out, in what scientists call a “massive step” in successfully treating these debilitating chronic conditions. Researchers at the Francis Crick Institute, in collaboration with University College London (UCL) and Imperial College London (ICL), have uncovered a problem gene enhancer that stimulates action along a specific biological pathway that causes IBD inflammation.
Bottom trawling, a practice criticized by NGOs for impacting ecosystems, involves dragging heavy nets over the seabed, damaging ecosystems, and releasing carbon into the oceans. Sweden is set to become the second EU country to ban bottom fishing in marine protected areas, going a step further than Greece’s April decision by banning it in all territorial waters.
An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases. Jemperli from British pharmaceutical company GSK showed “unprecedented results”, the firm said, with no evidence of disease in all patients treated. The data showed all 42 patients in a trial led by Memorial Sloan Kettering Cancer Center in the U.S. had a complete response to treatment, with no evidence of tumors on scans.
The number of abortions among women under 20 rose during the 1990s in Finland, leading the Nordic country to make morning-after pills available without prescription from 15 years of age and sexual education compulsory in all schools. As a result, the number of abortions fell 66% to 722 in 2023 from 2,144 in 2000 among all teenagers aged 19 or younger in Finland, while the drop was even steeper at 78% among those under 18 in the same period.
An “ultra-sensitive” new blood test developed and tested by Institute of Cancer Research (ICR) London can predict if breast cancer will return years before the disease shows up on scans, researchers say. It picks up traces of a tumor’s DNA before a full relapse and was found to be 100% accurate at predicting which patients would see their cancer return. It is hoped that the test can allow treatment to start earlier and improve survival rates.
Cancer vaccine trials are now being fast-tracked through a landmark NHS program in England that matches patients with personalized mRNA vaccines built around their individual tumors. The Cancer Vaccine Launch Pad, operating across 30 hospitals, uses the same mRNA technology behind COVID-19 vaccines to design custom treatments targeting each patient’s unique cancer mutations. The program aims to eliminate remaining cancer cells after surgery before they can return. Early immune response data is encouraging, and a 2024 trial showed a 44% reduction in melanoma recurrence when similar vaccines were combined with immunotherapy.
Although the precise details of the agreement have not been made public, the Spanish government said its assistance would “allow Ukraine to prioritize its capacities, including its air defenses.” The bilateral deal was agreed two days after Russia’s onslaught in the north-eastern Ukrainian city of Kharkiv killed 18 people, and as E.U. leaders grow increasingly exasperated with Hungary’s efforts to block aid to Ukraine.
